While no FDA-approved indication exists for GLP-1 medications in lymphedema, emerging interest focuses on whether weight loss achieved through these agents might benefit obese patients with this condition
Initial weight changes may appear within 46 weeks, though meaningful weight reduction (typically 5% or more of initial body weight) generally occurs over 36 months
Semaglutide is the active ingredient in three different medications made by Novo Nordisk: Ozempic , Wegovy , and Rybelsus
Once oxidized by lipoxygenases (LOXs), these products can generate lipid peroxides like polyunsaturated fatty acid hydroperoxide (PUFA-OOH) (Liang et al., 2022)
If coverage remains unavailable, explore affordable tirzepatide options or compounded semaglutide as alternatives
Idiopathic neuropathy, prediabetes and the metabolic syndrome